Shopping Cart
- Remove All
![TargetMol](https://www.targetmol.com/storage/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $539 | Backorder |
Description | Tadnersen (BIIB078) is an antisense oligonucleotide (ASO) designed for the selective targeting of C9ORF72 transcript variants 1 and 3, specifically those carrying the expansion. |
In vitro | Tadnersen (BIIB078) is an RNAse H oligomer designed to selectively target and inhibit mutant C9ORF72 transcripts. It is primarily utilized in the study of Amyotrophic Lateral Sclerosis (ALS), focusing on understanding and potentially treating this condition. |
Alias | IONIS-C9Rx, BIIB078 |
Cas No. | 2170507-65-8 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.